相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis
Nicola J. Maney et al.
ARTHRITIS & RHEUMATOLOGY (2021)
The Interleukin-4 Receptor-Associated Kinase Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial
Aaron Winkler et al.
ARTHRITIS & RHEUMATOLOGY (2021)
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
Joost S. Vermaat et al.
HAEMATOLOGICA (2020)
Destablilization of TRAF6 by DRAK1 Suppresses Tumor Growth and Metastasis in Cervical Cancer Cells
Yuna Park et al.
CANCER RESEARCH (2020)
Lactobacillus sakeisuppresses collagen-induced arthritis and modulates the differentiation of T helper 17 cells and regulatory B cells
Jooyeon Jhun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies
Venkateshwar Rao Gummadi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein Degradation
Jing Zhang et al.
CELL CHEMICAL BIOLOGY (2020)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Hui Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
NF-κB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes
Leila Nejatbakhsh Samimi et al.
AUTOIMMUNITY HIGHLIGHTS (2020)
Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
Snigdha Samarpita et al.
ARTHRITIS RESEARCH & THERAPY (2020)
PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes
You-Jung Ha et al.
RHEUMATOLOGY (2019)
Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment
Ryan M. Young et al.
IMMUNOLOGICAL REVIEWS (2019)
Rebalancing Immune Homeostasis to Treat Autoimmune Diseases
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2019)
MYD88 L265P Mutation in Lymphoid Malignancies
Xinfang Yu et al.
CANCER RESEARCH (2018)
Role of Bruton's tyrosine kinase in B cells and malignancies
Simar Pal Singh et al.
MOLECULAR CANCER (2018)
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The mycotoxin alternariol suppresses lipopolysaccharide-induced inflammation in THP-1 derived macrophages targeting the NF-κB signalling pathway
Jessica Kollarova et al.
ARCHIVES OF TOXICOLOGY (2018)
Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All
Bijal Shah et al.
TRENDS IN CANCER (2018)
Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
Nisar A. Amin et al.
CLINICAL CANCER RESEARCH (2017)
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Peter C. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
KinMap: a web-based tool for interactive navigation through human kinome data
Sameh Eid et al.
BMC BIOINFORMATICS (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome
Jordina Rovira et al.
CLINICAL CANCER RESEARCH (2016)
Conformational dynamics of cancer-associated MyD88-TIR domain mutant L252P (L265P) allosterically tilts the landscape toward homo-dimerization
Chendi Zhan et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Reconstructing the TIR Side of the Myddosome: a Paradigm for TIR-TIR Interactions
Laurens Vyncke et al.
STRUCTURE (2016)
Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma
Shuang Q. Zhang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
R. Angelo de Claro et al.
CLINICAL CANCER RESEARCH (2015)
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
Priscilla N. Kelly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
PIM kinase (and Akt) biology and signaling in tumors
Noel A. Warfel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Ryan M. Young et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
Ryan M. Young et al.
SEMINARS IN HEMATOLOGY (2015)
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
D. L. Boyle et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4
Y. Park et al.
ONCOGENE (2015)
Proposal for a new nomenclature of disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization
Monika Avbelj et al.
BLOOD (2014)
Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase
Matthew S. Davids et al.
FUTURE ONCOLOGY (2014)
Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies
D. Nagel et al.
ONCOGENE (2014)
Ibrutinib for B cell malignancies
Aileen Novero et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2014)
Serine/Threonine Kinase 17A Is a Novel Candidate for Therapeutic Targeting in Glioblastoma
Pingping Mao et al.
PLOS ONE (2013)
B cell receptor signaling in chronic lymphocytic leukemia
Jan A. Burger et al.
TRENDS IN IMMUNOLOGY (2013)
Biology and significance of the JAK/STAT signalling pathways
Hiu Kiu et al.
GROWTH FACTORS (2012)
Dysregulation of immune homeostasis in autoimmune diseases
Vijay K. Kuchroo et al.
NATURE MEDICINE (2012)
Integration of B cell responses through Toll-like receptors and antigen receptors
David J. Rawlings et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms
Methvin Isaac et al.
DRUG RESISTANCE UPDATES (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
Laurent Brault et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
Beatrix Bartok et al.
IMMUNOLOGICAL REVIEWS (2010)
Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios
Florence Loong et al.
MODERN PATHOLOGY (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
Zhi-Zhang Yang et al.
CANCER RESEARCH (2009)
Animal models of rheumatoid arthritis
Darren L. Asquith et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The role of Toll-like receptors in rheumatoid arthritis
Qi-Quan Huang et al.
Current Rheumatology Reports (2009)
Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases
Manolis Pasparakis
NATURE REVIEWS IMMUNOLOGY (2009)
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
Gerlincle Wernig et al.
BLOOD (2008)
IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver
Tom Luedde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The 44-kDa pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells
Yingqiu Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Amelioration of chronic murine colitis by peptide-mediated transduction of the IκB kinase inhibitor NEMO binding domain peptide
Shaival H. Dave et al.
JOURNAL OF IMMUNOLOGY (2007)
Bruton's tyrosine kinase mediates NF-κB activation and B cell survival by B cell-activating factor receptor of the TNF-R family
Nicholas P. Shinners et al.
JOURNAL OF IMMUNOLOGY (2007)
Cutting edge:: The IκB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis
Wataru Shibata et al.
JOURNAL OF IMMUNOLOGY (2007)
The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis
Sandra M. Sacre et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma
Tom Luedde et al.
CANCER CELL (2007)
Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities
P. De Paepe et al.
LEUKEMIA (2007)
Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4
Hyung S. Youn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors
Shuji Tohda et al.
LEUKEMIA RESEARCH (2006)
Rituximab for the treatment of diffuse large B-cell lymphomas
Gerhard Held et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs
Y Xie et al.
ONCOGENE (2006)
NF-kappa B as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
J. A. Roman-Blas et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
The serine/threonine kinase pim-1
M Bachmann et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis
M Iwahashi et al.
ARTHRITIS AND RHEUMATISM (2004)
Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site
TLT Aho et al.
FEBS LETTERS (2004)
Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-γ
TRDJ Radstake et al.
ARTHRITIS AND RHEUMATISM (2004)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
IκB kinase signaling is essential for maintenance of mature B cells
M Pasparakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
M Pasparakis et al.
NATURE (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway
N Zhu et al.
JOURNAL OF IMMUNOLOGY (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway
U Senftleben et al.
SCIENCE (2001)
NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction
SS Makarov
ARTHRITIS RESEARCH (2001)
Rsk1 mediates a MEK-MAP kinase cell survival signal
A Shimamura et al.
CURRENT BIOLOGY (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
分享论文
